{"id":"NCT02261493","sponsor":"Allergan","briefTitle":"A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides","officialTitle":"Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10-27","primaryCompletion":"2015-06-03","completion":"2016-04-20","firstPosted":"2014-10-10","resultsPosted":"2017-07-25","lastUpdate":"2017-07-25"},"enrollment":787,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Facial Rhytides","Glabellar Rhytides"],"interventions":[{"type":"BIOLOGICAL","name":"OnabotulinumtoxinA","otherNames":["BOTOX® Cosmetic","botulinum toxin Type A"]},{"type":"DRUG","name":"Normal Saline","otherNames":[]}],"arms":[{"label":"OnabotulinumtoxinA Dose A","type":"EXPERIMENTAL"},{"label":"OnabotulinumtoxinA Dose B","type":"EXPERIMENTAL"},{"label":"Placebo followed by OnabotulinumtoxinA Dose A","type":"PLACEBO_COMPARATOR"}],"summary":"This is a safety and efficacy study of onabotulinumtoxinA in subjects with upper facial rhytides (forehead lines, glabellar lines, lateral canthal lines \\[crow's feet lines\\]).","primaryOutcome":{"measure":"Percentage of Subjects With ≥2-Grade Improvement From Baseline on Both the Investigator's and Subject's Facial Wrinkle Scale (FWS) Ratings of Forehead Line Severity at Maximum Eyebrow Elevation","timeFrame":"Baseline, Day 30","effectByArm":[{"arm":"Placebo (Normal Saline) Followed by OnabotulinumtoxinA Dose A","deltaMin":0.6,"sd":null},{"arm":"OnabotulinumtoxinA Dose B","deltaMin":45.6,"sd":null},{"arm":"OnabotulinumtoxinA Dose A","deltaMin":53,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":7},"locations":{"siteCount":24,"countries":["United States","Belgium","Germany","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":156},"commonTop":["Headache","Injection site bruising","Nasopharyngitis","Injection site haematoma"]}}